Abstract
In this issue of Neuron, the comprehensive and multidisciplinary results from Pinto etal. (2020) point to novel and widespread microglial dysfunction in Down syndrome that results in impaired cognitive ability. A common pharmaceutical (acetaminophen) is shown to offset these effects in mouse models.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have